http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102371784-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
| filingDate | 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102371784-B1 |
| titleOfInvention | Method for producing inhibitor of activated blood coagulation factor x (fxa) |
| abstract | It is a subject to provide a novel manufacturing method of the compound which is an FXa inhibitor, its salt, or their hydrate. A solution is a method for producing a compound represented by the following formula (X), etc., using a production method from a compound represented by the following formula (1-x) via a compound represented by the formula (1-1) or the like. A manufacturing method characterized in that. [In formula, X represents a halogen atom etc., and R< 1 > represents the phenyl group which may have a substituent.] |
| priorityDate | 2014-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.